1
/
of
1
Elabscience
SKU:E-CL-H1031
Human VEGFR-2/KDR(Vascular Endothelial Growth Factor Receptor 2) CLIA Kit
Human VEGFR-2/KDR(Vascular Endothelial Growth Factor Receptor 2) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Human VEGFR-2/KDR (Vascular Endothelial Growth Factor Receptor 2) CLIA Kit, a cutting-edge solution designed to facilitate accurate and efficient measurement of VEGFR-2/KDR levels in human samples. This state-of-the-art kit is meticulously crafted to cater to the needs of researchers and clinicians alike, enabling them to delve into the intricate mechanisms of angiogenesis and vascular endothelial growth factor signaling pathways.
The Human VEGFR-2/KDR CLIA Kit boasts a comprehensive set of components, meticulously curated to ensure optimal performance and reliability. With its high sensitivity and specificity, this kit empowers users to obtain precise and reproducible results, thereby enhancing the credibility of their research findings.
This innovative CLIA (Chemiluminescent Immunoassay) kit offers a streamlined workflow, allowing for swift and hassle-free analysis. Its user-friendly nature ensures that both seasoned professionals and novices can effortlessly navigate through the assay procedure, saving valuable time and effort.
The Human VEGFR-2/KDR CLIA Kit is engineered to exhibit exceptional versatility, accommodating a wide range of sample types, including serum, plasma, and cell culture supernatants. This adaptability enables researchers to explore various biological matrices, facilitating a comprehensive understanding of VEGFR-2/KDR expression patterns across diverse experimental settings.
Furthermore, this CLIA kit adheres to stringent quality control measures, ensuring the utmost accuracy and reliability of results. Rigorous testing and validation procedures have been implemented to guarantee the kit's performance consistency, thereby instilling confidence in its users.
In summary, the Human VEGFR-2/KDR CLIA Kit represents a breakthrough in the field of angiogenesis research, offering a robust and user-friendly solution for the precise measurement of VEGFR-2/KDR levels in human samples. With its exceptional sensitivity, versatility, and reliability, this kit is poised to revolutionize the study of vascular endothelial growth factor receptor 2, empowering researchers and clinicians to unravel the complexities of angiogenesis and contribute to advancements in therapeutic interventions.
The Human VEGFR-2/KDR CLIA Kit boasts a comprehensive set of components, meticulously curated to ensure optimal performance and reliability. With its high sensitivity and specificity, this kit empowers users to obtain precise and reproducible results, thereby enhancing the credibility of their research findings.
This innovative CLIA (Chemiluminescent Immunoassay) kit offers a streamlined workflow, allowing for swift and hassle-free analysis. Its user-friendly nature ensures that both seasoned professionals and novices can effortlessly navigate through the assay procedure, saving valuable time and effort.
The Human VEGFR-2/KDR CLIA Kit is engineered to exhibit exceptional versatility, accommodating a wide range of sample types, including serum, plasma, and cell culture supernatants. This adaptability enables researchers to explore various biological matrices, facilitating a comprehensive understanding of VEGFR-2/KDR expression patterns across diverse experimental settings.
Furthermore, this CLIA kit adheres to stringent quality control measures, ensuring the utmost accuracy and reliability of results. Rigorous testing and validation procedures have been implemented to guarantee the kit's performance consistency, thereby instilling confidence in its users.
In summary, the Human VEGFR-2/KDR CLIA Kit represents a breakthrough in the field of angiogenesis research, offering a robust and user-friendly solution for the precise measurement of VEGFR-2/KDR levels in human samples. With its exceptional sensitivity, versatility, and reliability, this kit is poised to revolutionize the study of vascular endothelial growth factor receptor 2, empowering researchers and clinicians to unravel the complexities of angiogenesis and contribute to advancements in therapeutic interventions.
Share
